plasticity. 6 A growing body of evidence has demonstrated that abnormal VSMC proliferation and migration are key events underlying many VSMC-related pathological conditions, such as hypertension and postangioplasty restenosis. 7 The Hippo/Yes-associated protein (YAP) signalling pathway is an evolutionarily conserved molecular mechanism that has been reported to be closely related to vascular pathophysiological regulation and dysregulation. 8 YAP-null mice die at embryonic day 8.5 due to defects in yolk sac vasculogenesis, suggesting that YAP plays a fundamental role in vasculogenesis. 9 Moreover, Wang et al 10 reported that YAP expression was upregulated after vascular injury.
However, the role of the Hippo/YAP pathway in HVR still remains unknown. Angiotensin II (Ang II) has been reported to induce HVR and VSMCs phenotypic modulation. 11, 12 However, the effect of Ang II on the Hippo/YAP pathway in VSMCs has not been reported. Ang II exerts its biological function via two receptors, angiotensin receptor type 1 (AT1R) and AT2R, both of which belong to the G proteincoupled receptor (GPCR) family. Recently, GPCRs were reported to be able to serve as upstream regulators of Hippo/YAP signalling.
13-15
Based on these findings, this study aimed to characterize the role of the Hippo/YAP pathway in Ang II-induced HVR and VSMCs phenotypic modulation and to explore the underlying mechanisms.
| ME THODS

| Animals
Twenty male 9-to 10-week-old Sprague-Dawley rats were purchased from the Laboratory Animal Research Center of Southern Medical University (Guangzhou, China). All animals were maintained in a 12:12 h light-dark cycle at an ambient temperature of 23-25°C and 40%-60% humidity with free access to standard rodent chow and water.
After a 1-week acclimatization period, the animals were randomly assigned to the following four groups (n = 5 for each group):
the control group received a continuous infusion of phosphate-buffered saline (PBS); the Ad-YAP-shRNA group received continuous PBS infusion and Ad-YAP-shRNA transfer in the right common carotid artery (RCCA); the Ang II + Ad-GFP group and the Ang II + Ad-YAP-shRNA group received Ad-GFP and Ad-YAP-shRNA RCCA transfer, respectively, in addition to continuous Ang II infusion.
This protocol was approved by the Academic Administration
Committee of Sun Yat-sen Memorial Hospital of Sun Yat-sen University, and all animal experiments were performed in accordance with the NIH Guidelines for the Care and Use of Laboratory Animals.
| Construction of the YAP-shRNA adenovirus and carotid artery adventitial gene transfer
The YAP-shRNA adenovirus was designed and constructed by Hanbio
Company (Shanghai, China) based on the pHBAd-U6-Scramble-CMV-GFP vector. According to Wang et al, 10 the sequence of shRNA targeting rat YAP 3′-UTR was 5′-GCTGCCACCAAGTT-3′. Prior to use, Ad-GFP or Ad-YAP-shRNA was suspended in Pluronic F127 gel (20% w/v; Sigma-Aldrich, St. Louis, MO, USA) at a 1:9 ratio with a final concentration of 3.5 × 10 9 PFU/mL.
Application of the adenovirus was performed as previously described by Liu et al. 16 Briefly, rats were anaesthetized by intraperitoneal administration of sodium pentobarbital (40 mg/kg; Sigma-Aldrich), and then the RCCA was exposed. Two hundred microlitre of Pluronic F127 gel containing the adenovirus was carefully applied to the adventitial surface of the RCCA, whereas the control group received gel alone. After coagulation of the gel, the incision was closed, and rats were allowed to recover from anaesthesia.
| Osmotic minipump implantation and systolic blood pressure measurements
An osmotic minipump (2002; Alzet Osmotic Pumps, Cupertino, CA, USA) was used to ensure that the drug was continually and constantly delivered. The pumps were filled with either Ang II (SigmaAldrich) or PBS and implanted according to the manufacturer's instructions. The minipump was inserted into the abdominal cavity.
Ang II was continually infused at a rate of 0.5 μg/kg/min, whereas the two control groups received PBS infusion at the same rate and volume.
The systolic blood pressure (SBP), heart rate, and body weight were measured in conscious rats using the computerized caudal artery tail-cuff system (BP-98A; Softron, Tokyo, Japan) on days 0, 3, 7, and 14.
F I G U R E 1 YAP upregulation by Ang II. An HVR rat model was established by continuous Ang II infusion for 2 weeks. YAP was knockdown by adventitial application of the Ad-YAP-shRNA. Values were presented as the mean ± SEM. A, Temporal trend of SBP and heart rate which were measured using a caudal artery tail-cuff system on days 0, 3, 7, and 14 after treatment. B and C, Ang II regulated YAP and LATS1 expression and phosphorylation in the RCCAs. Densitometric quantification and representative western blots of total protein lysates for YAP and LATS1 were shown. Data were normalized to the housekeeping proteins GAPDH. D, Ang II regulated the gene expression of Yap1 and Last1 were analysed using quantitative real-time polymerase chain reaction. Data were expressed relative to the control (set to 1) after normalization to GAPDH (served as an internal control). E, Immunohistochemical staining of YAP in RCCAs. F, Quantitative analysis of the relative MOD (related to the control group) shown in (E). *P < 0.05 compared with the control group, **P < 0.01 compared with the control group; #P < 0.05 compared with the Ang II + Ad-GFP group, ##P < 0.01 compared with the Ang II + Ad-GFP group. HVR, hypertensive vascular remodelling; RCCA, right common carotid artery; MOD, mean optical density; SBP, systolic blood pressure; LATS1, large tumour suppressor kinase 1; GAPDH, glyceraldehyde phosphate dehydrogenase (n = 5)
| Histological assays and morphometric analyses
Two weeks after the intervention, the rats were euthanized, and the RCCAs were harvested. All RCCAs were fixed, paraffin-embedded, sectioned, and stained with haematoxylin and eosin, Masson's Trichrome or Vitoria blue (to detect elastic fibres) following standard protocols. Cross-sectional images were captured using a light microscope (Olympus, Tokyo, Japan) and measured using the Image-Pro Plus The reaction was visualized with diaminobenzidine, and the sections were counterstained with haematoxylin. The mean optical density of each group was determined using the Image-Pro Plus software (Media Cybernetics).
| Culture and stimulation of rat VSMCs
Rat VSMCs were isolated from the thoracic aortas as previously described. 17 The VSMCs were cultured in Dulbecco's modi- 
| Extraction of cytoplasmic/nuclear proteins and Western blot analysis
Proteins from cultured cells or rat carotid arteries were extracted and prepared following standard protocols and as previously described by our laboratory. 18 Nuclear and cytoplasmic extracts were prepared using NE-PER Nuclear and Cytoplasmic Extraction Next, the membranes were incubated with the appropriate horseradish peroxidase-conjugated secondary antibodies for 1 hour at room temperature.
All proteins were visualized and detected using an enhanced chemiluminescence detection system (Bio-Rad, Hercules, CA, USA). The band density was captured and quantified using the ImageJ software (http://rsbweb.nih.gov/ij/).
| RNA extraction and quantitative real-time PCR
Total RNA was extracted from tissue or VSMCs using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and cDNA was synthesized with the PrimeScript ® RT Master Mix (Takara Bio, Kusatsu, Japan).
The mRNA levels were quantified in triplicate using quantitative Supplementary Table S1 . All primers were designed using Primer Premier 6 or adopted as previously reported, 19, 20 and were synthesized by Invitrogen. The PCR cycling conditions were as follows:
one cycle at 95°C for 10 minutes, followed by 40 cycles at 95°C for 5 seconds, 60°C for 20 seconds and 72°C for 15 seconds. At the end of the reaction, the samples were subjected to additional reaction steps at 95°C for 5 seconds, 60°C for 60 seconds, 95°C for 5 seconds, and 60°C for 20 seconds to generate a dissociation curve. The dissociation curve analysis confirmed that the signals corresponded to unique amplicons. All reactions were performed in triplicate.
Specific mRNA expression levels were normalized to the GAPDH mRNA levels using the comparative ΔΔCt method. 
| Immunofluorescence staining
Vascular smooth muscle cells were seeded onto coverslips and treated. Afterwards, the VSMCs were fixed with 4% paraformaldehyde for 30 minutes and then permeabilized with 0.1% Triton X-100.
F I G U R E 2 YAP mediated Ang II-induced hypertensive vascular remodelling independent of the blood pressure levels. Two weeks after continuous infusion with either Ang II or PBS, and adventitial gene transfer with either adenovirus (Ad-YAP-shRNA or Ad-GFP) or gel on the RCCAs, RCCAs were harvested for histological assessments and morphometric analyses. A, H&E staining, Vitoria blue staining for elastic fibres and Masson's Trichrome staining for collagen. Intact elastic arrangement of the RCCAs media was noted whereas no obvious collagen deposition had been demonstrated by Masson staining among groups. B, Quantitative analysis of the vascular remodelling parameters, including medial thickness, medial CSA and the M/L CSA ratio calculated from (A). *P < 0.05 compared with the control group, **P < 0.01 compared with the control group; #P < 0.05 compared with the Ang II + Ad-GFP group, ##P < 0.01 compared with the Ang II + Ad-GFP group. PBS, phosphate-buffered saline (n = 5)
Regulation of YAP and LATS1 by Ang II. Rat VSMCs (70%-80% confluence) underwent mitogenic quiescence by incubation in DMEM supplemented with 0.1% FBS for 48 h and were subsequently stimulated with Ang II at either the indicated concentrations for 24 h or 10 −7 mol/L Ang II for the indicated times. A and B, Ang II regulated YAP and LATS1 expression and phosphorylation in a dose-and time-dependent manner. Densitometric quantification and representative Western blots of total protein lysates for YAP and LATS1 were shown. The data were normalized to the housekeeping proteins β-tubulin or GAPDH as indicated. C, Temporal changes in the mRNA of Yap1 and Lats1 were analysed using quantitative real-time polymerase chain reaction. The data were expressed relative to the control (0 h, set to 1) after normalization to GAPDH (served as an internal control). All results were presented as the mean ± SEM of three independent experiments performed in triplicate. *P < 0.05 compared with the control group, **P < 0.01 compared with the control group. GAPDH, glyceraldehyde phosphate dehydrogenase counterstained with DAPI to visualize the nuclei (blue). Immunofluorescence images were acquired using a confocal microscope (Zeiss). Scale bars represent 10 μm. B, Rat VSMCs were treated with or without Ang II (10 −7 mol/L) for 30 min. Nuclear and cytoplasmic fractions were extracted, and the protein levels of YAP in different fractions were measured by Western blot analysis. C, Quantification of YAP level in nuclear and cytoplasmic fractions in (B). The protein levels of YAP in nuclear or cytoplasmic fractions were normalized to H3 or GAPDH, respectively, and compared to that in the PBS control (set as 1). All results were presented as the mean ± SEM of three independent experiments performed in triplicate. *P < 0.05 compared with the control group, **P < 0.01 compared with the control group. GAPDH, glyceraldehyde phosphate dehydrogenase
| Construction of the YAP-shRNA plasmid and transfection into VSMCs
Three YAP1-shRNA sequences were designed using Primer Premier 6.0 as follows: 5′-CCATAAGAACAAGACCACA-3′;
5′-GGTCAGAGATACTTCTTAA-3′ and 5′-GGCAGGCAATACGGAATAT-3′. A scrambled sequence served as a control. The YAP-shRNA plasmids were constructed based on the pRNAT-U6.1/Neo backbone system (RioBo Bio, Guangzhou, China).
VSMCs were transfected with the YAP-shRNA plasmids using the Lipofectamine 3000 Transfection kit (Thermo Scientific) following the manufacturer's protocol.
| VSMC proliferation assay
Vascular smooth muscle cells proliferation was determined using the 5- VSMC migration was quantified by measuring the change in distance between the wound edges using the ImageJ software. 
| VSMC transwell migration assay
| Statistical analysis
Continuous variables were presented as the mean ± standard error of the mean, whereas categorical variables were expressed as percentages. Differences between two mean values were analysed using Student's t-test. Multiple mean values were compared using either one-way ANOVA or the Kruskal-Wallis test depending on the variable type. A two-tailed P value <0.05 was considered significant. All analyses were performed using the SPSS 13.0 software (SPSS, Inc., Chicago, IL , USA), and figures were generated using the GraphPad Prism 6.0 software (GraphPad Software, San Diego, CA, USA).
| RE SULTS
| In vivo silencing of YAP ameliorated Ang II-induced vascular remodelling through a blood pressure-independent mechanism
The Ang II-infused rats displayed significantly higher SBPs, heart rates, VSMCs were seeded into 12-well plates and grown to a confluent density. Cell migration was assayed 16 h after a wound was scratched across the cell monolayer under serum-free conditions, and the relative closure distance was measured. D, Quantification of the gap distance relative to the control (set to 1). E, VSMCs were seeded into Transwell chambers with 8.0-μm pores and allowed to migrate for 12 h. The migrated cells on the bottom surface of the membrane were stained with DAPI to visualize the nuclei (blue) and detected using fluorescence microscopy. F, Quantification of the migrated cells (DAPI-positive) in low-power field shown in (E). G, Representative Western blotting analysis of total protein lysates from the cultured rat VSMCs treated with either 10 −7 mol/L Ang II or PBS for 24 h after serum starvation. H, the mRNA levels of different phenotypic markers were detected by quantitative real-time polymerase chain reaction. The data were expressed relative to the control (set to 1) after normalization to GAPDH (served as an internal control). Scale bars in A and E represent 80 μm. All results from B, D, and F were presented as the mean ± SEM from three independent experiments with five random fields counted per experiment. *P < 0.05 compared with the control group, **P < 0.01 compared with the control group; #P < 0.05 compared with the Ang II group, ##P < 0.01 compared with the Ang II group. CCND1, cyclin D1; PCNA, proliferating cell nuclear antigen Western blotting for YAP and LATS1 were shown. The data were normalized to GAPDH and expressed relative to the control values (set to 1). C, Representative immunofluorescence staining of YAP (red) and F-actin (Alexa Fluor ® 488 Phalloidin, green). All sections were counterstained with DAPI to visualize the nuclei (blue). Images were acquired using a Zeiss confocal microscope. Scale bars represent 10 μm. *P < 0.05 compared with the control group, **P < 0.01 compared with the control group; #P < 0.05 compared with the Ang II group, ##P < 0.01 compared with the Ang II group. Lat B, latrunculin B. GAPDH, glyceraldehyde phosphate dehydrogenase the control group (PBS infusion alone), the Ang II-infused rats exhibited a significant increase in the media thickness, media area and media:lumen ratio, indicating that vascular remodelling had occurred.
However, this effect was significantly attenuated by YAP silencing Taken together, these data indicated that YAP mediated Ang II-induced vascular remodelling independent of changes in blood pressure.
| Ang II regulated YAP expression and promoted YAP nuclear accumulation in rat VSMCs
Ang II administration has been shown to increase YAP expression 
| YAP mediated Ang II-induced VSMC phenotypic modulation
Vascular smooth muscle cells phenotypic modulation is an important mechanism that contributes to vascular remodelling. Given the above results, we elected to investigate whether Ang II induced vascular remodelling via YAP-mediated VSMC phenotypic modulation. We 
| Ang II regulated YAP via an AT1R-and F-actindependent mechanism
We further explored the underlying mechanism by which Ang II regulated YAP. F-actin has been shown to be an important upstream regulator of Hippo/YAP signalling. 22 To further delineate the role of F- 
| D ISCUSS I ON
Unravelling the mechanisms involved in HVR is an important step towards better understanding of the pathology of Adventitial fibroblasts have been reported to participate in vascular remodelling. 26, 27 In response to stimulation, adventitial fibroblasts migrate from the adventitia into the media and intima.
During this process, fibroblasts display phenotypic modulation with a switch to myofibroblasts that possess greater secretion and contraction capabilities. YAP has been reported to be a driver of myofibroblast differentiation from dermal fibroblasts. 28 However, no obvious collagen deposition had been demonstrated both by 
The YAP-TEAD interaction mediated the induction of the VSMC synthetic phenotype by Ang II. Quiescent rat VSMCs were pretreated with 2 μg/mL of verteporfin (protected from light) or buffer (DMSO) for 48 h prior to Ang II stimulation (10 −7 mol/L for different times as indicated). A and B, Representative EdU proliferation assay images and quantification of the percentages of proliferating cells (EdU-positive cells). The cells were subjected to immunofluorescence staining for EdU (green) and counterstained with Hoechst 33342 to visualize the nuclei (blue). C and D, Representative scratch migration assay images and quantification of the gap distance relative to the control (set to 1). VSMCs were seeded into 12-well plates at a confluent density. The relative closure distance was measured 16 h after a wound was scratched across the cell monolayer under serum-free conditions. E and F, Representative Transwell migration assay images and quantification. The migrated cells were visualized by staining with DAPI (blue) and detected via fluorescence microscopy. G and H, Representative Western blotting analysis and densitometric quantification of total protein lysates from cultured rat VSMCs to detect the expression of synthetic markers cyclin D1 and PCNA. The data were normalized to β-tubulin and expressed relative to the control values (set to 1). I, the mRNA level of cyclin D1 and PCNA were detected by quantitative real-time polymerase chain reaction. The data were expressed relative to the control (set to 1) after normalization to GAPDH (served as an internal control). Scale bars in A and E represent 80 μm. All results from B, D, and F were presented as the mean ± SEM from three independent experiments with five randomly selected fields counted per experiment. *P < 0.05 compared with the control group, **P < 0.01 compared with the control group; #P < 0.05 compared with the Ang II group, ##P < 0.01 compared with the Ang II group. DMSO, dimethyl sulphoxide; CCND1, cyclin D1; PCNA, proliferating cell nuclear antigen remained elusive. 31 In this study, we demonstrated that Ang II regulated YAP expression and dephosphorylation in VSMCs via AT1R rather than AT2R ( Figure 5A ).
Consistent with the findings of previous studies, 32, 33 we also showed that F-actin was a crucial upstream mediator of YAP activation ( Figure 5B ). F-actin can regulate YAP either directly or indirectly. As mentioned above, the Hippo/YAP pathway was regulated by cell contact, cell adhesion, apical-basal polarity, and GPCRs signalling. One common feature of these regulatory mechanisms is involvement of the actin cytoskeleton. F-actin can act as a signal convergence for these upstream stimulators. 22 Additionally, both mammalian STE20-like protein kinase 1/2 (MST1/2) and LATS1 have been shown to bind or colocalize with F-actin, 34 is beyond the scope of this study but requires further evaluation.
Notwithstanding these limitations, this study has provided new insights into how Hippo/YAP signalling mediates Ang II-induced VSMC phenotypic modulation and HVR.
In conclusion, this study provided evidence that YAP played a critical role in Ang II-induced HVR and VSMCs phenotypic modulation and that YAP may be a potential therapeutic target for HVR beyond blood pressure control.
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